A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for older patients with AML
| Image |  |
|---|---|
| Description | scientific article published on 01 April 2022 |
| Author/s |
author: Maria T Voso Brian A. Fox |
| Publication date | April 1, 2022 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |